Stay updated on Biomarker-Guided Immunotherapy Discontinuation Clinical Trial
Sign up to get notified when there's something new on the Biomarker-Guided Immunotherapy Discontinuation Clinical Trial page.

Latest updates to the Biomarker-Guided Immunotherapy Discontinuation Clinical Trial page
- ChecktodayChange DetectedNew entries were added to the record history on 2026-06-18 introducing Contacts/Locations and updating the Study Status, reflecting changes in how to reach the study and its current recruitment status. An earlier entry dated 2026-05-14 was removed from the history.SummaryDifference0.4%

- Check7 days agoChange DetectedRecruitment status updated to not recruiting, indicating participants are no longer being sought. The version history shows a new revision tag v3.6.0 and removal of v3.5.5.SummaryDifference0.4%

- Check15 days agoChange DetectedA new revision entry, v3.5.5, was added to the study history and the previous revision, v3.5.4, was removed from the list. This update reflects changes to the record's version history rather than substantive content changes to the trial.SummaryDifference0.1%

- Check36 days agoChange DetectedThe Record History now shows a new version entry (version 17) with revision v3.5.4 and introduces Contacts/Locations and Study Status sections; the older revision v3.5.3 has been removed.SummaryDifference0.5%

- Check43 days agoChange DetectedA new version entry (Version 16, dated 2026-04-29) appears in the Record History with a Study Status update. A new last-update timestamp (2026-05-05) is added, and an older entry dated 2026-03-23 is removed.SummaryDifference0.4%

- Check57 days agoChange DetectedThe page now displays a newer ClinicalTrials.gov revision identifier (v3.5.3 instead of v3.5.2). This reflects an update to the site’s current software version without changing the study record details.SummaryDifference0.1%

Stay in the know with updates to Biomarker-Guided Immunotherapy Discontinuation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker-Guided Immunotherapy Discontinuation Clinical Trial page.